v3.26.1

Commitments and Contingencies (Tables) | 12 Months Ended
--- | ---
Dec. 31, 2025
Commitments and Contingencies [Abstract] |
Schedule of Milestone Payments that the Group is Required to Pay up to Different Achievements | The aggregate amounts of the contingent milestone payments that the Group is required to pay up to different achievements of conditions and milestones under all license agreements in effect as of December 31, 2025 are below:
|  | Amount
Drug molecules: up to the conditions and milestones of |  |  |
From entering phase 1 to before first commercial sale |  |  | 920,000
First commercial sale |  |  | 800,000
Net sales amount more than certain threshold in a year |  |  | 7,000,000
Subtotal |  | $ | 8,720,000

X
- Definition Tabular disclosure of milestone payments are to be made upon achievements of certain conditions. + References No definition available. + Details
Name: | apm_ScheduleOfMilestonePaymentsAreToBeMadeUponAchievementsOfCertainConditionsTableTextBlock
Namespace Prefix: | apm_
Data Type: | dtr:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- References No definition available. + Details
Name: | us-gaap_CommitmentsAndContingenciesDisclosureAbstract
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration